Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.51 |
| ▸ | LPL | P06858 | 8/20 | 0.51 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21781485 | 0.93 | LIPG (0.52) | LIPGLPLDGAT1P4HBSNCA | |
| SCHEMBL20407029 | 0.93 | LIPG (0.52) | LIPGLPLDGAT1P4HBSNCA | |
| SCHEMBL20038797 | 0.87 | LIPG (0.39) | LIPGLPL | |
| SCHEMBL19774525 | 0.87 | LIPG (0.40) | LIPGLPL | |
| SCHEMBL16189113 | 0.83 | LPL (0.34) | LIPGLPL | |
| SCHEMBL23075595 | 0.82 | LPL (0.40) | LIPGLPLSNCACA1CA2 | |
| SCHEMBL29313718 | 0.79 | LPL (0.36) | LIPGLPL | |
| SCHEMBL21781499 | 0.78 | LIPG (0.41) | LIPGLPLDGAT1 | |
| SCHEMBL20038798 | 0.78 | NISCH (0.39) | — | |
| SCHEMBL18644042 | 0.77 | NOS2 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200308150-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | HEESUNG MATERIAL LTD. (KR) | 2020-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308150-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | LIPG 3750/4885LPL 3165/4885DGAT1 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.